GT Biopharma, Inc. (GTBP) vs Healthcare Triangle, Inc. (HCTI)
A side-by-side comparison of GT Biopharma, Inc. and Healthcare Triangle, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GTBP
GT Biopharma, Inc.
$6.30HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
HCTI
Healthcare Triangle, Inc.
$0.57HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — GTBP vs HCTI
growth of $100 · dividends reinvested · last 5yGTBP -99.9% (-73.6%/yr)HCTI -100.0% (-93.5%/yr)GTBP compounded faster over this window
Log scale — wide-divergence pair
GTBP HCTI
GTBP vs HCTI: by the numbers
- •HCTI is the larger company ($8M vs $8M market cap).
- •Both run net losses; GTBP's is the smaller (0.00% vs -66.29% net margin).
Metrics side by side
Valuation
| Metric | GTBP | HCTI |
|---|---|---|
| P/S ratio | N/A | 0.33 |
| P/B ratio | 2.23 | 0.20 |
Profitability
| Metric | GTBP | HCTI |
|---|---|---|
| Gross margin | 0.00% | 18.37% |
| Operating margin | 0.00% | -70.47% |
| Net margin | 0.00% | -66.29% |
| ROE | -618.74% | -34.67% |
| ROIC | -457.75% | -21.90% |
Growth (annualized)
| Metric | GTBP | HCTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -15.02% |
| Total return CAGR (5Y) | -73.13% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.